Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 141-150 of 193 for Skin cancer

Edit search filters
  1. Diagnosing Lymphangioleiomyomatosis from Glycoprotein Non-Metastatic Melanoma Protein B

    Rochester, MN

  2. Using Social Media for Public Health Education on Melanoma within the Hispanic Population

    Scottsdale/Phoenix, AZ

  3. Melanoma In-transit Tissue Bank and Molecular Analysis for Personalized Therapies

    Rochester, MN, Jacksonville, FL

  4. MElanoma Research Lymph node prediction Implementation National_001 (MERLIN_001)

    Rochester, MN

  5. A Study to Assess the Molecular Differences in Primary Malignant Melanoma and Healthy Tissue

    Scottsdale/Phoenix, AZ

  6. A Study to Evaluate Cemiplimab Survivorship Epidemiology

    Jacksonville, FL

  7. A Study to Better Understand How to Predict and Manage Patients Who are at High Risk for Developing Rheumatic Immune-related Adverse Events While Receiving Treatment for Melanoma

    Rochester, MN

  8. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients

    Rochester, MN

  9. Rare Cutaneous Tumors and Unresolved Issues with the Current AJCC Cutaneous Carcinoma Staging System

    Rochester, MN

  10. Innovative CAR-TIL immunotherapy against melanoma

    Jacksonville, FL

.

Mayo Clinic Footer